Your browser doesn't support javascript.
loading
The vanillin derivative 6-bromine-5-hydroxy-4-methoxybenzaldehyde induces aberrant mitotic progression and enhances radio-sensitivity accompanying suppression the expression of PLK1 in esophageal squamous cell carcinoma.
Gu, Meng-Meng; Li, Ming; Gao, Dexuan; Liu, Lang-Huan; Lang, Yue; Yang, Si-Ming; Ou, Hongling; Huang, Bo; Zhou, Ping-Kun; Shang, Zeng-Fu.
Afiliação
  • Gu MM; State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, Medical College of Soochow University, Suzhou 215123, PR China; Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou 215123, P
  • Li M; State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, Medical College of Soochow University, Suzhou 215123, PR China; Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou 215123, P
  • Gao D; Department of Urology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan 250021, PR China.
  • Liu LH; School of Public Heath, Central South University, Changsha 410078, PR China.
  • Lang Y; State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, Medical College of Soochow University, Suzhou 215123, PR China; Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou 215123, P
  • Yang SM; State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, Medical College of Soochow University, Suzhou 215123, PR China; Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou 215123, P
  • Ou H; Department of Clinical Laboratory, The General Hospital of the PLA Rocket Force, Beijing 100088, PR China.
  • Huang B; School of Public Heath, Central South University, Changsha 410078, PR China.
  • Zhou PK; State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, Medical College of Soochow University, Suzhou 215123, PR China; Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou 215123, P
  • Shang ZF; State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, Medical College of Soochow University, Suzhou 215123, PR China; Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou 215123, P
Toxicol Appl Pharmacol ; 348: 76-84, 2018 06 01.
Article em En | MEDLINE | ID: mdl-29679654

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tolerância a Radiação / Benzaldeídos / Neoplasias Esofágicas / Carcinoma de Células Escamosas / Proteínas Proto-Oncogênicas / Proteínas Serina-Treonina Quinases / Proteínas de Ciclo Celular / Inibidores de Proteínas Quinases / Proliferação de Células / Quimiorradioterapia Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Toxicol Appl Pharmacol Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tolerância a Radiação / Benzaldeídos / Neoplasias Esofágicas / Carcinoma de Células Escamosas / Proteínas Proto-Oncogênicas / Proteínas Serina-Treonina Quinases / Proteínas de Ciclo Celular / Inibidores de Proteínas Quinases / Proliferação de Células / Quimiorradioterapia Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Toxicol Appl Pharmacol Ano de publicação: 2018 Tipo de documento: Article